相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine
Amanda J. Redig et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research
Donald A. Berry
MOLECULAR ONCOLOGY (2015)
Borrowing Information across Subgroups in Phase II Trials: Is It Useful?
Boris Freidlin et al.
CLINICAL CANCER RESEARCH (2013)
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
Scott M. Berry et al.
CLINICAL TRIALS (2013)
Implementing personalized cancer genomics in clinical trials
Richard Simon et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Markers Predicting Response to Bacillus Calmette-Guerin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review
Tahlita C. M. Zuiverloon et al.
EUROPEAN UROLOGY (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bayesian Inference in Semiparametric Mixed Models for Longitudinal Data
Yisheng Li et al.
BIOMETRICS (2010)
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
U Gatzemeier et al.
ANNALS OF ONCOLOGY (2004)
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
PF Thall et al.
STATISTICS IN MEDICINE (2003)
Bayesian measures of model complexity and fit
DJ Spiegelhalter et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2002)